NCT06741982
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, HNSCC, +10 more
- Locations
-
- West China Hospital, Sichuan University Chengdu, Sichuan, China
Clinical trial condition
Neoadjuvant Therapy
Explore clinical trials studying Neoadjuvant Therapy. Study availability and eligibility vary by location and protocol.
124 public trials
48 recruiting studies
Neoadjuvant Therapy trial results
Recruiting
Multimodal Prehabilitation During Chemotherapy in Patients With Colorectal Liver Metastases
NCT04520737
- Conditions
- Liver Metastases, Neoadjuvant Therapy, Prehabilitation
- Locations
-
- Hospital Universitari de Tarragona Joan XXIII Tarragona, Spain
NCT06354530
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
- Locations
-
- Army Medical Center of PLA Chongqing, None Selected, China
NCT06241807
- Conditions
- Biomarkers / Blood, Bronchial Neoplasms, Carcinoma, Bronchogenic, +11 more
- Locations
-
- Shandong Cancer Hospital and Institute Jinan, Shandong, China
NCT06102395
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +8 more
- Locations
-
- Beijing Tongren Hospital Beijing, Beijing Municipality, China
NCT04743102
- Conditions
- Colorectal Neoplasms, Complete Remission, Digestive System Diseases, +19 more
- Locations
-
- Beijing Chaoyang Hospital Beijing, Beijing Municipality, China
NCT04486495
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +11 more
- Locations
-
- Jeroen Bosch Hospital 's-Hertogenbosch, Netherlands
- Northwest Clinics Alkmaar, Netherlands
- The Netherlands Cancer Institute Amsterdam, Netherlands
- Gelre Hospital Apeldoorn, Netherlands
NCT05406999
- Conditions
- High Risk Prostate Cancer, Intense Endocrine Therapy, Locally Advanced Prostate Cancer, +1 more
- Locations
-
- Department of Urology, Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University Nanjing, Jiangsu, China
NCT07829471
- Conditions
- Clinical Outcomes, Neoadjuvant Therapy, Pancreatic Adenocarcinoma, +2 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
Not yet recruiting
Neoadjuvant Therapy With Firmonertinib Combined With Anlotinib and Platinum-Based Doublet Chemotherapy for Resectable EGFR-Mutated NSCLC
NCT07807722
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- Hubei Cancer Hospital Wuhan, Hubei, China